Exterior of Plus Ultra Amsterdam at Amsterdam Medical Business Park

TEMPLATE: Plus Ultra Amsterdam

TEST: High-quality laboratory and office space

Are you looking for lab & office space in Amsterdam?

A valuable network of locally connected science clusters enhances proximity to various resources. Our Global Connectivity adds an extra dimension to our specialised assets in local clusters by providing opportunities to connect with others from our global network.

Connectivity leverages the full power of our network of science clusters to support growth for our clients.

  • Present in 6 countries
  • In 4 innovative sectors
  • At 27 leading campuses
  • With 69 assets
  • And 400+ clients

Join these innovative companies at Plus Ultra Amsterdam

Logo's van partners
Logo's van partners
Logo's van partners
Logo's van partners
Logo's van partners
Logo's van partners
Logo's van partners

Why Plus Ultra Amsterdam?

Advanced Molecular and Cellular Mechanisms

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

Data and Artificial Intelligence

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Drug Discovery, Development and Manufacturing

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

Are you ready to accelerate your innovation?

Join Kadans at Plus Ultra Amsterdam today!

Lucienne Coppoolse
Lucienne Coppoolse Asset Manager – West NL